These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23551874)

  • 21. Comorbidity in chronic obstructive pulmonary disease. Related to disease severity?
    Echave-Sustaeta JM; Comeche Casanova L; Cosio BG; Soler-Cataluña JJ; Garcia-Lujan R; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1307-14. PubMed ID: 25429213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Clinical Study of Comorbidities and Systemic Inflammation in COPD].
    Huang YL; Min J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Mao B
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):88-108. PubMed ID: 31037911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of comorbidities on long-term outcomes after thoracoscopic surgery for stage I non-small cell lung cancer patients with chronic obstructive pulmonary disease.
    Shibazaki T; Odaka M; Noda Y; Tsukamoto Y; Mori S; Asano H; Yamashita M; Morikawa T
    J Thorac Dis; 2018 Feb; 10(2):909-919. PubMed ID: 29607164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort.
    Lee JY; Chon GR; Rhee CK; Kim DK; Yoon HK; Lee JH; Yoo KH; Lee SH; Lee SY; Kim TE; Kim TH; Park YB; Hwang YI; Kim YS; Jung KS
    J Korean Med Sci; 2016 Apr; 31(4):553-60. PubMed ID: 27051239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of the overlap syndrome and its association with comorbidities in patients with chronic obstructive pulmonary disease.
    Steveling EH; Clarenbach CF; Miedinger D; Enz C; Dürr S; Maier S; Sievi N; Zogg S; Leuppi JD; Kohler M
    Respiration; 2014; 88(6):451-7. PubMed ID: 25472034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, Charlson comorbidity index, and neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: relationship to disease severity.
    Uzunlar EA; Yildiran H; Kokturk N; Kilic H; Hasanoglu HC
    Bratisl Lek Listy; 2023; 124(7):520-526. PubMed ID: 37218479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and Prevalence of Asthma/Chronic Obstructive Pulmonary Disease Overlap in the United States.
    Kumbhare S; Pleasants R; Ohar JA; Strange C
    Ann Am Thorac Soc; 2016 Jun; 13(6):803-10. PubMed ID: 26974689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
    Deng D; Zhou A; Chen P; Shuang Q
    Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of prevalent and new COPD cases in Greece: the GOLDEN study.
    Mitsiki E; Bania E; Varounis C; Gourgoulianis KI; Alexopoulos EC
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1371-82. PubMed ID: 26229456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study.
    Almagro P; Cabrera FJ; Diez J; Boixeda R; Alonso Ortiz MB; Murio C; Soriano JB;
    Chest; 2012 Nov; 142(5):1126-1133. PubMed ID: 23303399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.
    Laforest L; Roche N; Devouassoux G; Belhassen M; Chouaid C; Ginoux M; Van Ganse E
    Respir Med; 2016 Aug; 117():33-9. PubMed ID: 27492511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    von Siemens SM; Jörres RA; Behr J; Alter P; Lutter J; Lucke T; Söhler S; Welte T; Watz H; Vogelmeier CF; Trudzinski F; Rief W; Herbig B; Kahnert K;
    Respir Res; 2019 Feb; 20(1):30. PubMed ID: 30744630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent updates in chronic obstructive pulmonary disease.
    Garvey C
    Postgrad Med; 2016; 128(2):231-8. PubMed ID: 26560514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor of variegation 3-9 homologue 1 impairment and neutrophil-skewed systemic inflammation are associated with comorbidities in COPD.
    Chen TT; Wu SM; Chen KY; Tseng CH; Ho SC; Chuang HC; Feng PH; Liu WT; Han CL; Huang EW; Yeh YK; Lee KY
    BMC Pulm Med; 2021 Oct; 21(1):276. PubMed ID: 34598691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs.
    Choi HS; Rhee CK; Park YB; Yoo KH; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2873-2883. PubMed ID: 31849460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
    Ther Adv Respir Dis; 2023; 17():17534666231167353. PubMed ID: 37073797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.